Author

Grayson Tilstra

University of TorontoORCID 0000-0001-6652-6273Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1 Assay:multiome· 1

Frequent Co-Authors

Julien Couture‐SenécaliD· 2 shared Omar F. KhaniD· 2 shared Alanna M. ManningiD· 1 shared Ana-Maria OproescuiD· 1 shared Atul Humar· 1 shared Janice PangiD· 1 shared Karlene L. M. KnaggsiD· 1 shared Meng Qi JiangiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Julien Couture‐SenécalORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintDec 17, 2025

The Clearance of Human Cytomegalovirus Using CRISPR/Cas9 RNA Lipid Nanoparticles

Yan Ming Anson Lau, Janice Pang, Meng Qi Jiang…·Omar F. Khan

This study develops CRISPR/Cas9 RNA lipid nanoparticles to clear HCMV infections, showing high efficacy and broad strain coverage.

DOI 10.64898/2025.12.17.694960

humangenetic perturbation / CRISPR

𝕏 PostBluesky

BioengineeringbioRxivPreprintAug 2, 2024

Engineering ionizable lipids for rapid biodegradation balances mRNA vaccine efficacy and tolerability

Julien Couture‐Senécal, Grayson Tilstra, Omar F. Khan

This study designs and tests biodegradable ionizable lipids for mRNA vaccines, showing they balance efficacy and tolerability by reducing inflammation while maintaining strong immune responses.

16 citations

𝕏 PostBluesky